Worktype B4 - DISSOLUTION STUDIES OF

Worktype Details

CodeB4
NameDISSOLUTION STUDIES OF

Experiments (70 results)

Filters
Worktypes (23)
70
13
13
12
11
8
6
4
4
4
3
3
3
2
2
2
2
1
1
1
1
1
1
No match
Compounds (37)
19
4
4
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
7
No match
Organisms (67)
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
70 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
332413
DISSOLUTION STUDIES OFABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
80179
DISSOLUTION STUDIES OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Sapindus mukorossi (SAPINDACEAE)
MUKUROZIOSIDE II-B
319080
DISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
GRISEOFULVIN
329848
DISSOLUTION STUDIES OFPHYSICAL CHARACTERISTICS OF FORMULATIONSABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
325047
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
325474
DISSOLUTION STUDIES OFREVIEW OF
Empty organism
320819
DISSOLUTION STUDIES OFPATENT DESCRIBED
Empty organism
SORBITOLMANNITOL
322979
DISSOLUTION STUDIES OFPHARMACEUTICAL FORMULATION OF
Empty organism
ASCORBIC ACID
319227
DISSOLUTION STUDIES OF
Empty organism
DIGOXIN
318386
PHARMACOKINETIC/BIOAVAILABITY STUDYDISSOLUTION STUDIES OF
Empty organism
DIGOXIN
328772
DISSOLUTION STUDIES OFPHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
DIGOXIN
317212
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
329174
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPHYSICAL CHARACTERISTICS OF FORMULATIONSREVIEW OF
Empty organism
325667
DISSOLUTION STUDIES OFPHARMACEUTICAL FORMULATION OFSOLUBILITY STUDIES OF
Empty organism
CAFFEINE
328118
DISSOLUTION STUDIES OFSTABILITY STUDIES OFPHARMACEUTICAL FORMULATION OFABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
319111
DISSOLUTION STUDIES OF
Empty organism
DIGOXIN
319389
DISSOLUTION STUDIES OFABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
319226
DISSOLUTION STUDIES OF
Empty organism
DIGOXIN
326320
DISSOLUTION STUDIES OFPHARMACEUTICAL FORMULATION OF
Empty organism
TRAGACANTH GUM
325870
DISSOLUTION STUDIES OF
Empty organism
DIGOXIN
325598
DISSOLUTION STUDIES OF
Empty organism
DIGOXIN
80178
DISSOLUTION STUDIES OFQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Sapindus mukorossi (SAPINDACEAE)
MUKUROZIOSIDE II-A
331270
DISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ABSORPTION/DISTRIBUTION STUDY
Empty organism
CHLORAMPHENICOL
341189
DISSOLUTION STUDIES OFSOLUBILITY STUDIES OF
Empty organism
BENZOIC ACID,PARA-AMINO:CAFFEINE
329005
DISSOLUTION STUDIES OFPATENT DESCRIBED
Empty organism
AESCIN,BETA:
321147
DISSOLUTION STUDIES OFABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
318610
DISSOLUTION STUDIES OFPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hordeum vulgare (POACEAE)
STARCH
321169
DISSOLUTION STUDIES OF
Empty organism
THEOPHYLLINE
331106
DISSOLUTION STUDIES OFPHYSICAL CHARACTERISTICS OF FORMULATIONSABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
317996
DISSOLUTION STUDIES OF
Empty organism
ACACIA GUM
319081
DISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
AMPHOTERICIN B
1157633
DISSOLUTION STUDIES OF
Empty organism
GOSSYPOL
321164
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
SUCROSE
319146
PHARMACOKINETIC/BIOAVAILABITY STUDYDISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
TETRACYCLINE,OXY:
405377
DISSOLUTION STUDIES OFPHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
QUINIDINEQUINIDINE,HYDRO:
329839
PHARMACOKINETIC/BIOAVAILABITY STUDYDISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
TETRACYCLINE
328852
DISSOLUTION STUDIES OFPHARMACEUTICAL FORMULATION OFPHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
ASCORBIC ACID
325010
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
321468
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
GLUTATHIONE
80177
DISSOLUTION STUDIES OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Sapindus mukorossi (SAPINDACEAE)
MUKUROZIOSIDE I-B
1089102
DISSOLUTION STUDIES OFMARKER CODE - FERTILITY REGULATION. NO RETRIEVABLE DATAWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Gossypium barbadense (MALVACEAE)
GOSSYPOL
319524
DISSOLUTION STUDIES OFABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
329279
DISSOLUTION STUDIES OFPHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
QUINIDINE
319078
DISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
TETRACYCLINETETRACYCLINE,OXY:
319507
DISSOLUTION STUDIES OF
Empty organism
EPHEDRINE
319225
DISSOLUTION STUDIES OF
Empty organism
CAFFEINE
318611
DISSOLUTION STUDIES OFPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Secale cereale (POACEAE)
STARCH
328551
DISSOLUTION STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHYSICAL CHARACTERISTICS OF FORMULATIONSABSORPTION/DISTRIBUTION STUDY
Empty organism
DOXYCYCLINE*
331446
DISSOLUTION STUDIES OFPHARMACEUTICAL FORMULATION OF
Empty organism
CAFFEINE
328116
DISSOLUTION STUDIES OFPHARMACEUTICAL FORMULATION OFABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
330349
DISSOLUTION STUDIES OFPHARMACEUTICAL FORMULATION OFPHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
QUININE
319257
DISSOLUTION STUDIES OF
Empty organism
QUINIDINE
321144
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFISOLATION AND IDENTIFICATION OF AN ARTIFACTQUANTITATIVE DATA REPORTED
Empty organism
DIGITOXIN
80176
DISSOLUTION STUDIES OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Sapindus mukorossi (SAPINDACEAE)
MUKUROZIOSIDE I-A
321137
DISSOLUTION STUDIES OFPHARMACEUTICAL ANALYSIS OFPHARMACEUTICAL FORMULATION OF
Empty organism
DIGOXIN
319521
DISSOLUTION STUDIES OFABSORPTION/DISTRIBUTION STUDY
Empty organism
RESERPINE
328600
DISSOLUTION STUDIES OF
Empty organism
DIGOXIN
318628
DISSOLUTION STUDIES OFCHEMICAL CONVERSION OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACEUTICAL FORMULATION OF
Empty organism
LEUCOMYCIN A-5
319515
DISSOLUTION STUDIES OF
Empty organism
QUINIDINE
329295
DISSOLUTION STUDIES OFPHYSICAL CHARACTERISTICS OF FORMULATIONSABSORPTION/DISTRIBUTION STUDY
Empty organism
DIGOXIN
319196
DISSOLUTION STUDIES OF
Empty organism
NICOTINIC ACIDASCORBIC ACID
318612
DISSOLUTION STUDIES OFPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Triticum aestivum (POACEAE)
STARCH
325090
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
320838
DISSOLUTION STUDIES OFPURIFICATION OFPHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
CETOSTEARYL ALCOHOL
321133
DISSOLUTION STUDIES OFSTABILITY STUDIES OFPHARMACEUTICAL FORMULATION OF
Empty organism
RESERPINE
323296
DISSOLUTION STUDIES OFPHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
DIGOXIN
328771
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPHYSICAL CHARACTERISTICS OF FORMULATIONS
Empty organism
325821
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
BENZOIC ACID
321148
DISSOLUTION STUDIES OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Empty organism
DOPA,L:
321096
DISSOLUTION STUDIES OFPATENT DESCRIBED
Empty organism
MALTITOL
Show SPARQL Queries (1)